Amgen (AMGN) |
United States |
$143.346B |
15.00 |
Bristol Myers Squibb (BMY) |
United States |
$139.866B |
9.72 |
CSL (CSLLY) |
Australia |
$91.779B |
0.00 |
Gilead Sciences (GILD) |
United States |
$81.977B |
9.18 |
Illumina (ILMN) |
United States |
$58.852B |
89.64 |
Moderna (MRNA) |
United States |
$56.442B |
0.00 |
Vertex Pharmaceuticals (VRTX) |
United States |
$55.220B |
23.58 |
Regeneron Pharmaceuticals (REGN) |
United States |
$50.906B |
16.64 |
Biogen (BIIB) |
United States |
$40.852B |
8.17 |
Alexion Pharmaceuticals (ALXN) |
United States |
$34.079B |
13.27 |
BioNTech SE (BNTX) |
Germany |
$29.499B |
763.38 |
BeiGene (BGNE) |
Cayman Islands |
$28.269B |
0.00 |
Seagen (SGEN) |
United States |
$25.900B |
44.36 |
Genmab (GMAB) |
Denmark |
$22.418B |
31.36 |
Exact Sciences (EXAS) |
United States |
$21.228B |
0.00 |
Genmab (GNMSF) |
Denmark |
$21.156B |
5.01 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$20.498B |
23.52 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.921B |
0.00 |
Incyte (INCY) |
United States |
$17.579B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$16.217B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$15.858B |
90.83 |
Guardant Health (GH) |
United States |
$15.784B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$14.261B |
0.00 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.014B |
111.70 |
Novavax (NVAX) |
United States |
$13.275B |
0.00 |
Zai Lab (ZLAB) |
China |
$11.750B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$11.693B |
23.86 |
Repligen (RGEN) |
United States |
$11.288B |
124.16 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$8.730B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$8.616B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$7.681B |
0.00 |
AbCellera Biologics (ABCL) |
|
$7.640B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$7.314B |
0.00 |
Exelixis (EXEL) |
United States |
$7.213B |
66.06 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$6.928B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$6.752B |
0.00 |
Twist Bioscience (TWST) |
United States |
$6.433B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$6.323B |
201.00 |
Halozyme Therapeutics (HALO) |
United States |
$6.129B |
47.52 |
NeoGenomics (NEO) |
United States |
$5.638B |
688.14 |
Adaptive Biotechnologies (ADPT) |
United States |
$5.627B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$5.602B |
0.00 |
Vir Biotechnology (VIR) |
United States |
$5.520B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$5.457B |
17.97 |
Galapagos (GLPG) |
Belgium |
$5.097B |
0.00 |
SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.086B |
15.99 |
Intellia Therapeutics (NTLA) |
United States |
$4.784B |
0.00 |
Atea Pharmaceuticals (AVIR) |
United States |
$4.675B |
0.00 |
Beam Therapeutics (BEAM) |
United States |
$4.387B |
0.00 |
Biohaven Pharmaceutical Holding (BHVN) |
United States |
$4.305B |
0.00 |
Certara (CERT) |
United States |
$4.124B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$4.123B |
9.85 |
Arena Pharmaceuticals (ARNA) |
United States |
$4.000B |
0.00 |
Legend Biotech (LEGN) |
United States |
$3.784B |
0.00 |
I-Mab (IMAB) |
China |
$3.716B |
0.00 |
SpringWorks Therapeutics (SWTX) |
United States |
$3.377B |
0.00 |
Apellis Pharmaceuticals (APLS) |
United States |
$3.340B |
0.00 |
Insmed (INSM) |
United States |
$3.274B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$3.263B |
0.00 |
Reata Pharmaceuticals (RETA) |
United States |
$3.201B |
0.00 |
Seer (SEER) |
|
$3.167B |
0.00 |
Berkeley Lights (BLI) |
United States |
$3.131B |
0.00 |
Arvinas (ARVN) |
United States |
$3.103B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.029B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$3.022B |
42.81 |
MorphoSys AG (MOR) |
Germany |
$2.942B |
44.72 |
Vericel (VCEL) |
United States |
$2.663B |
1155.40 |
Editas Medicine (EDIT) |
United States |
$2.658B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$2.564B |
0.00 |
ALX Oncology Holdings (ALXO) |
United States |
$2.559B |
0.00 |
Ligand Pharmaceuticals (LGND) |
United States |
$2.549B |
48.25 |
Global Blood Therapeutics (GBT) |
United States |
$2.534B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$2.525B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.429B |
0.00 |
Amarin (AMRN) |
Ireland |
$2.333B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$2.218B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$2.118B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$2.109B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$2.055B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$2.031B |
0.00 |
Genetron Holdings (GTH) |
China |
$2.012B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$2.008B |
0.00 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.991B |
0.00 |
NGM Biopharmaceuticals (NGM) |
United States |
$1.950B |
0.00 |
Morphic Holding (MORF) |
United States |
$1.926B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$1.891B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$1.884B |
0.00 |
Heska (HSKA) |
United States |
$1.843B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$1.816B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$1.767B |
0.00 |
Castle Biosciences (CSTL) |
United States |
$1.736B |
0.00 |
Cytokinetics (CYTK) |
United States |
$1.728B |
0.00 |
ADC Therapeutics SA (ADCT) |
Switzerland |
$1.653B |
0.00 |
Harmony Biosciences Holdings (HRMY) |
United States |
$1.611B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.584B |
0.00 |
Travere Therapeutics (TVTX) |
United States |
$1.548B |
0.00 |
Codexis (CDXS) |
United States |
$1.546B |
0.00 |
Immunocore Holdings (IMCR) |
|
$1.530B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.518B |
0.00 |
Kymera Therapeutics (KYMR) |
United States |
$1.499B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.495B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$1.456B |
364.88 |
Precigen (PGEN) |
United States |
$1.446B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.431B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.424B |
0.00 |
MiMedx (MDXG) |
United States |
$1.415B |
0.00 |
C4 Therapeutics (CCCC) |
United States |
$1.408B |
0.00 |
Keros Therapeutics (KROS) |
United States |
$1.400B |
0.00 |
Alector (ALEC) |
United States |
$1.382B |
0.00 |
Forma Therapeutics Holdings (FMTX) |
United States |
$1.322B |
0.00 |
Ocugen (OCGN) |
United States |
$1.309B |
0.00 |
Nurix Therapeutics (NRIX) |
United States |
$1.290B |
0.00 |
Pliant Therapeutics (PLRX) |
United States |
$1.212B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$1.197B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$1.179B |
0.00 |
Shattuck Labs (STTK) |
United States |
$1.179B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.167B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$1.164B |
0.00 |
Y-mAbs Therapeutics (YMAB) |
United States |
$1.148B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$1.140B |
0.00 |
Repare Therapeutics (RPTX) |
Canada |
$1.138B |
0.00 |
Mesoblast (MESO) |
Australia |
$1.104B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$1.092B |
0.00 |
G1 THERAPEUTICS (GTHX) |
United States |
$1.073B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$1.069B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.063B |
0.00 |
Nkarta (NKTX) |
United States |
$1.059B |
0.00 |
MannKind (MNKD) |
United States |
$1.056B |
0.00 |
Curis (CRIS) |
United States |
$1.052B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$1.026B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.015B |
8.25 |
Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.972B |
0.00 |
KaloBios Pharmaceuticals (HGEN) |
United States |
$0.923B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.922B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.911B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.892B |
37.79 |
Adverum Biotechnologies (ADVM) |
United States |
$0.888B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.879B |
0.00 |
Affimed (AFMD) |
Germany |
$0.860B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.852B |
0.00 |
Epizyme (EPZM) |
United States |
$0.852B |
0.00 |
Pharming Group (PHAR) |
Netherlands |
$0.847B |
0.00 |
Bolt Biotherapeutics (BOLT) |
United States |
$0.842B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$0.832B |
0.00 |
Avidity Biosciences (RNA) |
United States |
$0.831B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.820B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.820B |
21.83 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.785B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.775B |
0.00 |
Inhibrx (INBX) |
United States |
$0.774B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$0.732B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.716B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.714B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.662B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.655B |
0.00 |
Cel-Sci (CVM) |
United States |
$0.654B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.651B |
0.00 |
IDEAYA Biosciences (IDYA) |
United States |
$0.641B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
ChromaDex (CDXC) |
United States |
$0.632B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.631B |
0.00 |
DBV Technologies S.A (DBVT) |
France |
$0.631B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.629B |
0.00 |
ALBIREO PHARMA (ALBO) |
United States |
$0.628B |
0.00 |
Adagene (ADAG) |
|
$0.627B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.591B |
0.00 |
Compugen (CGEN) |
Israel |
$0.576B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.571B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.570B |
189.52 |
Agenus (AGEN) |
United States |
$0.570B |
0.00 |
Inventiva S.A (IVA) |
France |
$0.558B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.539B |
0.00 |
Forte Biosciences (FBRX) |
United States |
$0.536B |
0.00 |
RAPT THERAPTICS (RAPT) |
United States |
$0.523B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.516B |
0.00 |
AMMO (POWW) |
United States |
$0.508B |
0.00 |
Neoleukin Therapeutics (NLTX) |
United States |
$0.507B |
0.00 |
Amryt Pharma (AMYT) |
United Kingdom |
$0.502B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.500B |
0.00 |
XBiotech (XBIT) |
United States |
$0.499B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.494B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.490B |
0.00 |
Verastem (VSTM) |
United States |
$0.474B |
0.00 |
Geron (GERN) |
United States |
$0.471B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.470B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.466B |
0.00 |
Angion Biomedica (ANGN) |
United States |
$0.456B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.445B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.444B |
0.00 |
XOMA (XOMA) |
United States |
$0.439B |
97.47 |
SESEN BIO, INC (SESN) |
United States |
$0.427B |
0.00 |
Seelos Therapeutics (SEEL) |
United States |
$0.427B |
0.00 |
Opthea (OPT) |
Australia |
$0.420B |
0.00 |
Adicet Bio (ACET) |
United States |
$0.419B |
0.00 |
Lineage Cell Therapeutics (LCTX) |
United States |
$0.417B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.415B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.403B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.401B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.394B |
10.99 |
Fulcrum Therapeutics (FULC) |
United States |
$0.388B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.386B |
0.00 |
Athenex (ATNX) |
United States |
$0.383B |
0.00 |
Athersys (ATHX) |
United States |
$0.383B |
0.00 |
SQZ Biotechnologies (SQZ) |
United States |
$0.381B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.380B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.376B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.374B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.373B |
0.00 |
Frequency Therapeutics (FREQ) |
United States |
$0.370B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.370B |
0.00 |
CorMedix Inc (CRMD) |
United States |
$0.361B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.358B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.358B |
14.20 |
HOOKIPA Pharma (HOOK) |
United States |
$0.356B |
0.00 |
Cardiff Oncology (CRDF) |
United States |
$0.348B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.343B |
0.00 |
Codiak BioSciences (CDAK) |
United States |
$0.341B |
0.00 |
Innate Pharma S.A (IPHA) |
France |
$0.337B |
0.00 |
Arbutus Biopharma (ABUS) |
United States |
$0.318B |
0.00 |
IBio (IBIO) |
United States |
$0.315B |
0.00 |
ProQR Therapeutics (PRQR) |
Netherlands |
$0.313B |
0.00 |
Cogent Biosciences (COGT) |
United States |
$0.308B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$0.305B |
0.00 |
Kaleido Biosciences (KLDO) |
|
$0.300B |
0.00 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.293B |
0.00 |
Trevena (TRVN) |
United States |
$0.290B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.288B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.283B |
0.00 |
Kamada (KMDA) |
Israel |
$0.273B |
15.74 |
NextCure (NXTC) |
United States |
$0.266B |
0.00 |
Cerecor (CERC) |
United States |
$0.250B |
0.00 |
OVID THERAPEUTC (OVID) |
United States |
$0.243B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.229B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.222B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.222B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.213B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.213B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.207B |
0.00 |
TELA Bio (TELA) |
United States |
$0.198B |
0.00 |
LogicBio Therapeutics (LOGC) |
United States |
$0.197B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.194B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
Aptinyx (APTX) |
United States |
$0.191B |
0.00 |
VolitionRX (VNRX) |
United States |
$0.190B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.189B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.186B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.185B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.183B |
0.00 |
Voyager Therapeutics (VYGR) |
United States |
$0.179B |
5.01 |
Exicure (XCUR) |
United States |
$0.179B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.178B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.177B |
0.00 |
Nicox SA (NICXF) |
France |
$0.176B |
0.00 |
INmune Bio (INMB) |
United States |
$0.176B |
0.00 |
ObsEva SA (OBSV) |
Switzerland |
$0.175B |
0.00 |
Chiasma (CHMA) |
United States |
$0.174B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.167B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.166B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.162B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.160B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.159B |
0.00 |
X4 Pharmaceuticals (XFOR) |
United States |
$0.157B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.153B |
0.00 |
Palatin Technologies (PTN) |
United States |
$0.151B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.150B |
0.00 |
Eyenovia (EYEN) |
United States |
$0.147B |
0.00 |
Evofem Biosciences (EVFM) |
United States |
$0.145B |
0.00 |
Erytech Pharma SA (ERYP) |
France |
$0.144B |
0.00 |
Dyadic (DYAI) |
United States |
$0.142B |
0.00 |
Galena Biopharma (SLS) |
United States |
$0.136B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.133B |
0.00 |
Synlogic (SYBX) |
United States |
$0.132B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.130B |
266.50 |
Aytu BioPharma (AYTU) |
United States |
$0.129B |
0.00 |
Novogen (KZIA) |
Australia |
$0.129B |
0.00 |
Zosano Pharma (ZSAN) |
United States |
$0.129B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.127B |
0.00 |
Liminal BioSciences (LMNL) |
Canada |
$0.123B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.122B |
0.00 |
Beyond Air (XAIR) |
United States |
$0.122B |
0.00 |
Evogene (EVGN) |
Israel |
$0.120B |
0.00 |
Armata Pharmaceuticals (ARMP) |
United States |
$0.115B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.114B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.112B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.111B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.108B |
0.00 |
Ecology Coatings (ABVC) |
United States |
$0.107B |
0.00 |
Leap Therapeutics (LPTX) |
United States |
$0.107B |
0.00 |
Celsion (CLSN) |
United States |
$0.101B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.101B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.099B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.097B |
0.00 |
Cyclerion Therapeutics (CYCN) |
United States |
$0.097B |
0.00 |
F-star Therapeutics (FSTX) |
United Kingdom |
$0.095B |
0.00 |
Lumos Pharma (LUMO) |
United States |
$0.094B |
0.00 |
AIkido Pharma (AIKI) |
United States |
$0.092B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.090B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.083B |
0.00 |
Advaxis (ADXS) |
United States |
$0.080B |
0.00 |
CollPlant Biotechnologies (CLGN) |
Israel |
$0.078B |
0.00 |
Timber Pharmaceuticals (TMBR) |
United States |
$0.078B |
0.00 |
Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.078B |
0.00 |
Adocia (ADOCY) |
France |
$0.077B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.077B |
0.00 |
CytRx (CYTR) |
United States |
$0.077B |
0.00 |
Purple Biotech (PPBT) |
Israel |
$0.076B |
0.00 |
Edesa Biotech (EDSA) |
Canada |
$0.075B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.073B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.073B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.072B |
0.00 |
BioCardia (BCDA) |
United States |
$0.071B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.069B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.069B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.067B |
0.00 |
AnPac Bio-Medical Science (ANPC) |
China |
$0.065B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.064B |
0.00 |
ARIDIS PHARMACT (ARDS) |
United States |
$0.063B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.063B |
0.00 |
Soligenix (SNGX) |
United States |
$0.060B |
0.00 |
ZIVO Bioscience (ZIVO) |
United States |
$0.059B |
0.00 |
Enzon Pharmaceuticals (ENZN) |
United States |
$0.058B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.057B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.055B |
0.00 |
Enveric Biosciences (ENVB) |
United States |
$0.054B |
0.00 |
Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.054B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.053B |
0.00 |
Happiness Biotech Group (HAPP) |
China |
$0.052B |
0.00 |
Appili Therapeutics (APLIF) |
Canada |
$0.052B |
0.00 |
Yumanity Therapeutics (YMTX) |
United States |
$0.047B |
0.00 |
Cyclo Therapeutics (CYTH) |
United States |
$0.046B |
0.00 |
PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.045B |
0.00 |
Vyant Bio (VYNT) |
United States |
$0.044B |
0.00 |
Clene (CLNN) |
Hong Kong, SAR China |
$0.043B |
0.00 |
Invo BioScience (INVO) |
United States |
$0.043B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.040B |
0.59 |
Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.040B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.033B |
0.00 |
ThermoGenesis Holdings (THMO) |
United States |
$0.033B |
0.00 |
Vallon Pharmaceuticals (VLON) |
United States |
$0.032B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.031B |
0.00 |
GeoVax Labs (GOVX) |
United States |
$0.030B |
0.00 |
Lexaria Bioscience (LEXX) |
Canada |
$0.028B |
0.00 |
Seneca Biopharma (SNCA) |
United States |
$0.027B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.027B |
0.00 |
Benitec Biopharma (BNTC) |
United States |
$0.024B |
0.00 |
Brooklyn ImmunoTherapeutics (BTX) |
United States |
$0.010B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$0.000B |
0.00 |
China Biologic Products (CBPO) |
China |
$0.000B |
29.28 |
Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
Immatics (IMTX) |
United States |
$0.000B |
0.00 |
Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |